The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

被引：0
|
作者：
Brandse, Johannan F.
van der Kleij, Desiree
Wolbink, Gert-Jan
Rigter, Irma M.
Baars, Paul A.
Lowenberg, M.
Ponsioen, Cyriel
Jansen, Jeroen M.
van den Brink, Gijs R.
Mathot, Ron A.
D'Haens, Geert R.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
786
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [1] Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
    Hyams, Jeffrey
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Subra
    Cohen, Stanley
    Markowitz, James
    Escher, Johanna C.
    Veereman-Wauters, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 391 - U169
  • [2] Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study
    Iwanczak, Barbara M.
    Kierkus, Jaroslaw
    Ryzko, Jozef
    Szczepanik, Mariusz
    Wiecek, Sabina
    Czaja-Bulsa, Grazyna
    Kacperska, Magdalena
    Korczowski, Bartosz
    Maslana, Jolanta
    Iwanczak, Franciszek
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (01): : 57 - 61
  • [3] Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
    Brandse, Johannan F.
    Mathot, Ron A.
    van der Kleij, Desiree
    Rispens, Theo
    Ashruf, Yael
    Jansen, Jeroen M.
    Rietdijk, Svend
    Lowenberg, Mark
    Ponsioen, Cyriel Y.
    Singh, Sharat
    van den Brink, Gijs R.
    D'Haens, Geert R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) : 251 - +
  • [4] Infliximab therapy for severe ulcerative colitis
    Fahrtash, Farzan
    Gibbs, Oliver
    Liddle, Christopher
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 102 - 102
  • [5] Can infliximab induction therapy prevent colectomy in moderate to severe steroid non responsive ulcerative colitis?
    Kordian, T.
    Rees, V.
    Mulanga, X.
    Rogge, C.
    Lee, T.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 107 - 107
  • [6] Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
    Vong, Camille
    Martin, Steven W.
    Deng, Chenhui
    Xie, Rujia
    Ito, Kaori
    Su, Chinyu
    Sandborn, William J.
    Mukherjee, Arnab
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (03): : 229 - 240
  • [7] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
    Berends, S.
    Strik, A.
    van Egmond, P.
    Brandse, H.
    Mathot, R.
    D'Haens, G.
    Lowenberg, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
  • [8] Intestinal ultrasonography accuracy in the evaluation of patients with moderate to severe ulcerative colitis starting infliximab therapy
    Albshesh, A.
    Melnik, P.
    Dotan, A.
    Lahat, A.
    Ungar, B.
    Ben-Horin, S.
    Carter, D.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1301 - I1301
  • [9] Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
    Ungar, B.
    Mazor, Y.
    Weisshof, R.
    Yanai, H.
    Ron, Y.
    Goren, I.
    Waizbard, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Loebstein, R.
    Kopylov, U.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1293 - 1299
  • [10] Changes in energy metabolism after induction therapy in patients with severe or moderate ulcerative colitis
    Inoue, Mai
    Sasaki, Masaya
    Takaoka, Azusa
    Kurihara, Mika
    Iwakawa, Hiromi
    Bamba, Shigeki
    Ban, Hiromitsu
    Andoh, Akira
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2015, 56 (03) : 215 - 219
12345